11/21/2003 - Pinnacle Data Systems, Inc. (AMEX: PNS) (PDSi) announced that it has been awarded an order of approximately $3 million from a global medical diagnostic equipment provider. The order is for controller boards no longer in mass production that are needed to extend the product life of one of the world’s most advanced medical diagnostic machines.
“A key value driver for doing business with PDSi is our ability to extend the life of products our customers have invested five to ten years and millions of dollars in developing for the marketplace,” said John D. Bair, Chairman, CEO and President of PDSi. “We do that by managing the procurement or manufacturing of the basic printed circuit boards and related components that are no longer being mass-produced, storing them for the customer as needed, and manufacturing our end product as required. We also upgrade those boards to help our customer incorporate new advances in technology and help slow their product’s obsolescence.”
The timing of shipments against this order will be dependent upon the availability of components. However, PDSi expects to complete the order in the first half of 2004.
PDSi provides technical services and solutions, encompassing the development and production of embedded (built-in) computer systems and components, and the testing and repair of computer systems, components and peripherals, to Original Equipment Manufacturers (OEMs) in, among others, the computer, computer peripheral, data storage, digital-imaging, medical diagnostic, process-control and telecommunications equipment industries. PDSi offers a full range of services to increase product speed to market and engineered product life, and to provide service and support to units in the field through comprehensive product lifecycle management programs encompassing depot repair, advanced exchange, contact center support and end-of-life control. For more information, visit the PDSi Web site at www.pinnacle.com.
Safe Harbor Statement: Statements in this release which relate to other than strictly historical facts, including statements about the Company’s plans and strategies, as well as management’s expectations about new and existing products and services, technologies and opportunities, market growth, demand for acceptance of new and existing products and services are forward-looking statements. The words “believe,” “expect,” “anticipate,” “estimate,” “project,” and similar expressions identify forward-looking statements that speak only as of the date thereof. Investors are cautioned that such statements involve risks and uncertainties that could cause actual results to differ materially from historical or anticipated results due to many factors. The Company undertakes no obligations to publicly update or revise such statements. For more details, please refer to the Company’s Securities and Exchange Commission filings, including its most recent Annual Report on Form 10-KSB and quarterly reports on Form 10-QSB.
Previous Page | News by Category | News Search
If you found this page useful, bookmark and share it on: